Safe Opioid Prescribing in Primary Care: A Comprehensive Primer

Council Bluffs, IA US
March 29, 2018

Target Audience

All interested health providers. 

Purpose

This training covers the safe and competent use of opioids for managing chronic pain by reviewing best practices & sharing clinical pearls.

Objectives

  1. Explain the epidemiology of chronic pain and the misuse of opioids.
  2. Discuss indications for opioids prescribed for chronic pain treatment.
  3. Review tools for assessing risk and monitoring benefit and harm of opioids.
  4. Understand initiation and ongoing management of patients with chronic pain treated with opioid-based therapies.
  5. Review best practice methods for working with patients with aberrant medication use and at risk for diversion.
  6. Understand approach to discontinuing opioids for pain due to lack of benefits or increased risk.
  7. Understand the process for referring or initiating treatment for opioid addiction.
  8. Explore how to incorporate evidence-based, best-practices into your practice.
  9. Review systems approach to support prescribing of long-term opioids in your clinic.
  10. Review case studies of a patient with chronic pain.

Agenda

8 amRegistration
8:30 amPre-Test
8:45 amIntroduction and History of Opioids
9:15 amUnderstanding Opioid Addiction and Usage
9:45 am

Break

10 amAssessments
10:45 amTreatment Options and Tracking
11:30 amVideo and Case Review
12 pm

Adjourn

Speaker

Christopher W. Shanahan, MD, MPH
Director, Community Medicine Unit; Assistant Professor of Medicine, Boston University School of Medicine, Boston MA

Medical School

  • University of Medicine and Dentistry of New Jersey, Newark, NJ

Residency

  • Montefiore Medical Center, Bronx, NY 
  • Fellowship in General Internal Medicine, Beth Israel Hospital, Boston, MA

Full biography.

Relevant to the content of this CME activity, Dr. Shanahan indicated he has no financial relationships with commercial interests to disclose.

References

  • Alford DP et al. SCOPE of Pain: an evaluation of an opioid Risk Evaluation & Mitigation Strategy continuing education program. Pain Med. 2016;17:52-63 
  • Ballantyne JC, Mao J. N Engl J Med. 2003
  • Baron MJ, McDonald PW. J Opioid Manage. 2006
  • Breivik H, et al. Br J Anaesth. 2008
  • Chou R et al. Ann Intern Med. 2015
  • Dzau VJ, Pizzo PA. JAMA 2014
  • Eisenberg E, McNicol ED, Carr DB. JAMA. 2005
  • Furlan AD, et al. CMAJ. 2006
  • Institute of Medicine. 2011 Relieving Pain in America. Washington DC
  • Kelso E, et al. Pain. 2004
  • Krebs EE, et al. J Gen Intern Med. 2009
  • Martell BA, et al. Ann Intern Med. 2007
  • Michna E, et al. Pain Med 2014
  • McCleane G, Smith HS. Med Clin N Am 2007
  • Nilesen HK, et al. Acta Anaesthesiol Scand. 2010
  • Noble M, et al. Cochrane Systematic Reviews. 2010.
  • Reuben DB et al. Ann Intern Med. 2015
  • Salaffi F, et al. Best Pract Res Clin Rheumatol. 2015
  • Smith PC, et al. J Gen Intern Med. 2009 
  • Smith PC, et al. Arch Intern Med. 2010
  • Smith HS. Pain Physician. 2008
  • Walk D, Poliak-Tunis M. Med Clin N Am. 2016
Course summary
Available credit: 
  • 3.00 AOA Category 2­A
  • 3.00 AMA PRA Category 1 Credits
  • 3.00 IBON
  • 3.00 CE Contact Hours
Course opens: 
03/29/2018
Course expires: 
03/29/2018
Event starts: 
03/29/2018 - 8:30am
Event ends: 
03/29/2018 - 12:00pm
Cost:
$0.00
Rating: 
0
All Care Health Center
902 S. 6th Street
Council Bluffs, IA 51501
United States
+1 (712) 325-1990

Continuing Education Credit

  • MD:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and All Care Health Center. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 3.0 continuing education contact hour(s). No partial credit awarded.
  • Other Healthcare Professional: This live activity is designated for 3.0 AMA PRA Category 1 Credit(s)TM

Disclosure

Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Educational Grants

Supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

Available Credit

  • 3.00 AOA Category 2­A
  • 3.00 AMA PRA Category 1 Credits
  • 3.00 IBON
  • 3.00 CE Contact Hours

Accreditation Period

Course opens: 
03/29/2018
Course expires: 
03/29/2018

Price

Cost:
$0.00
Please login or Create an Account to take this course.
Registration


Cost: There is no cost to attend. 

Click here to register.

If you have questions, please contact Amy Hunzelman at 319-273-3660 or amy.hunzelman@uni.edu.